242 related articles for article (PubMed ID: 20814176)
21. Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients.
Buda-Nowak A; Kucharz J; Dumnicka P; Kuzniewski M; Herman RM; Zygulska AL; Kusnierz-Cabala B
Med Oncol; 2017 Apr; 34(4):68. PubMed ID: 28343336
[TBL] [Abstract][Full Text] [Related]
22. Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.
Koizumi Y; Hirooka M; Hiraoka A; Ochi H; Tanaka T; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Miyake T; Matsuura B; Michitaka K; Joko K; Abe M; Hiasa Y
Endocr J; 2019 Sep; 66(9):787-792. PubMed ID: 31142692
[TBL] [Abstract][Full Text] [Related]
23. Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression.
Kappers MH; van Esch JH; Smedts FM; de Krijger RR; Eechoute K; Mathijssen RH; Sleijfer S; Leijten F; Danser AH; van den Meiracker AH; Visser TJ
J Clin Endocrinol Metab; 2011 Oct; 96(10):3087-94. PubMed ID: 21816788
[TBL] [Abstract][Full Text] [Related]
24. The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study.
Baldazzi V; Tassi R; Lapini A; Santomaggio C; Carini M; Mazzanti R
Urol Oncol; 2012 Sep; 30(5):704-10. PubMed ID: 20884255
[TBL] [Abstract][Full Text] [Related]
25. Transient thyrotoxicosis occurred after cessation of steroid therapy in a patient with autoimmune thyroiditis and rheumatoid arthritis.
Maruyama H; Kato M; Mizuno O; Kataoka K; Matsuki S
Endocrinol Jpn; 1982 Oct; 29(5):583-8. PubMed ID: 6897816
[TBL] [Abstract][Full Text] [Related]
26. Primary hypothyroidism manifested in childhood with special reference to various types of reversible hypothyroidism.
Okamura K; Sato K; Ikenoue H; Nakagawa M; Kuroda T; Yoshinari M; Fujishima M
Eur J Endocrinol; 1994 Aug; 131(2):131-7. PubMed ID: 7915603
[TBL] [Abstract][Full Text] [Related]
27. A CT scan aspect of "hypodense thyroid gland" after sunitinib treatment for metastatic carcinoma of the kidney.
Vélayoudom-Céphise FL; Vian E; Bosewa T; Nallet E; Wemeau JL; Donnet JP
J Clin Endocrinol Metab; 2011 Mar; 96(3):590-1. PubMed ID: 21378222
[No Abstract] [Full Text] [Related]
28. Autoimmune thyroiditis with transient thyrotoxicosis: comparison between painful thyroiditis and painless thyroiditis.
Shigemasa C; Kouchi T; Taniguchi S; Mitani Y; Ueta Y; Yoshida A; Mashiba H
Horm Res; 1991; 36(1-2):9-15. PubMed ID: 1814808
[TBL] [Abstract][Full Text] [Related]
29. Does sunitinib-induced hypothyroidism play a role in the activity of sunitinib in metastatic renal cell carcinoma?
Sella A; Hercbergs AH; Hanovich E; Kovel S
Chemotherapy; 2012; 58(3):200-5. PubMed ID: 22759787
[TBL] [Abstract][Full Text] [Related]
30. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
Roti E; Minelli R; Gardini E; Bianconi L; Braverman LE
Arch Intern Med; 1993 Apr; 153(7):886-92. PubMed ID: 8466380
[TBL] [Abstract][Full Text] [Related]
31. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
Minelli R; Gardini E; Bianconi L; Salvi M; Roti E
J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine.
de Groot JW; Links TP; van der Graaf WT
Ann Oncol; 2006 Nov; 17(11):1719-20. PubMed ID: 16731538
[No Abstract] [Full Text] [Related]
33. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
Yamauchi I; Sakane Y; Fukuda Y; Fujii T; Taura D; Hirata M; Hirota K; Ueda Y; Kanai Y; Yamashita Y; Kondo E; Sone M; Yasoda A; Inagaki N
Thyroid; 2017 Jul; 27(7):894-901. PubMed ID: 28537531
[TBL] [Abstract][Full Text] [Related]
34. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
35. Thyroiditis: an integrated approach.
Sweeney LB; Stewart C; Gaitonde DY
Am Fam Physician; 2014 Sep; 90(6):389-96. PubMed ID: 25251231
[TBL] [Abstract][Full Text] [Related]
36. Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies.
Schwartz F; Bergmann N; Zerahn B; Faber J
Scand J Clin Lab Invest; 2013 Apr; 73(3):240-4. PubMed ID: 23438331
[TBL] [Abstract][Full Text] [Related]
37. Sunitinib-induced acute severe hypothyroidism in a case of metastatic gastrointestinal stromal tumor: A case report.
Manir KS; Banerjee D; Bhowmick R; Roy C
J Cancer Res Ther; 2018 Sep; 14(Supplement):S818-S819. PubMed ID: 30249914
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of thyrotoxic autoimmune thyroiditis patients with triplex Doppler ultrasonography.
Karakas O; Karakas E; Cullu N; Demir Y; Kucukyavas Y; Surucu E; Yener S; Igci E
Clin Imaging; 2014; 38(1):1-5. PubMed ID: 24119678
[TBL] [Abstract][Full Text] [Related]
39. Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: a cohort study.
Feldt S; Schüssel K; Quinzler R; Franzmann A; Czeche S; Ludwig WD; Schulz M
Eur J Cancer; 2012 May; 48(7):974-81. PubMed ID: 22382202
[TBL] [Abstract][Full Text] [Related]
40. Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report.
Sauter NP; Atkins MB; Mier JW; Lechan RM
Am J Med; 1992 Apr; 92(4):441-4. PubMed ID: 1558092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
